Stocks and Investing Stocks and Investing
Thu, May 12, 2022

Ed Arce Maintained (CDTX) at Strong Buy with Decreased Target to $120 on, May 12th, 2022


Published on 2024-10-27 21:01:40 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Decreased Target from $150 to $120 on, May 12th, 2022.

Ed, nor any peers, have made any analyst calls on CDTX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources